Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroscience ; 242: 39-52, 2013 Jul 09.
Article in English | MEDLINE | ID: mdl-23548516

ABSTRACT

The hematopoietic growth factor, granulocyte colony-stimulating factor (G-CSF), has become one of the few growth factors approved for clinical use. It has therapeutic potential for numerous neurodegenerative diseases; however, at present the cellular effects of G-CSF on the central nervous system remain unclear and in need of investigation. In the present study, we used spinal cord ischemia, a neurodegenerative model, to examine the effects of intrathecal (i.t.) G-CSF on glial cell (microglia and astrocyte) activation and neuroprotective factor expression, including glial cell line-derived neurotrophic factor (GDNF) and vascular endothelial growth factor A (VEGF-A) protein expression. Our results indicate that i.t. G-CSF could enhance ischemia-induced microglial activation and inhibit ischemia-induced astrocyte activation. Both GDNF and VEGF-A are upregulated after injury, and i.t. G-CSF could enhance GDNF and VEGF-A expressions after injury. Interestingly, our results indicate that performing i.t. G-CSF alone on normal animals could have the effect of microglial and astrocyte activation and enhanced GDNF and VEGF-A expressions. Furthermore, through laser scanning confocal microscopy, we found that astrocytes may contribute to the majority of GDNF and VEGF-A expressions of G-CSF after spinal cord ischemia. Overall, this G-CSF-induced upregulation suggests that activation of endogenous neuroprotective mechanisms could resist neurodegenerative insults. These observations demonstrate the cellular mechanism of i.t. G-CSF after spinal cord ischemia and confirm the neuroprotective effect of G-CSF after spinal cord ischemia injury.


Subject(s)
Astrocytes/drug effects , Glial Cell Line-Derived Neurotrophic Factor/biosynthesis , Granulocyte Colony-Stimulating Factor/administration & dosage , Granulocyte Colony-Stimulating Factor/pharmacology , Ischemia/metabolism , Spinal Cord/pathology , Vascular Endothelial Growth Factor A/biosynthesis , Animals , Astrocytes/metabolism , Gene Expression Regulation/drug effects , Granulocyte Colony-Stimulating Factor/therapeutic use , Injections, Spinal , Ischemia/drug therapy , Ischemia/pathology , Male , Microglia/drug effects , Neuroprotective Agents/administration & dosage , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Rats , Rats, Wistar , Recovery of Function , Spinal Cord/drug effects , Up-Regulation/drug effects
2.
Sex Dev ; 5(3): 124-30, 2011.
Article in English | MEDLINE | ID: mdl-21654186

ABSTRACT

WNT signalling plays a central role in mammalian sex determination by promoting ovarian development and repressing aspects of testis development in the early gonad. Dickkopf homolog 1 (DKK1) is a WNT signalling antagonist that plays critical roles in multiple developmental systems by modulating WNT activity. Here, we examined the role of DKK1 in mouse sex determination and early gonadal development. Dkk1 mRNA was upregulated sex-specifically during testis differentiation, suggesting that DKK1 could repress WNT signalling in the developing testis. However, we observed overtly normal testis development in Dkk1-null XY gonads, and found no significant upregulation of Axin2 or Sp5 that would indicate increased canonical WNT signalling. Nor did we find significant differences in expression of key markers of testis and ovarian development. We propose that DKK1 may play a protective role that is not unmasked by loss-of-function in the absence of other stressors.


Subject(s)
Gonads/growth & development , Gonads/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Animals , Female , In Situ Hybridization , Intercellular Signaling Peptides and Proteins/genetics , Male , Mice , Mice, Knockout , Ovary/growth & development , Ovary/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sex Determination Processes/genetics , Sex Determination Processes/physiology , Testis/growth & development , Testis/metabolism
3.
Appl Environ Microbiol ; 74(5): 1642-5, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18165364

ABSTRACT

A CadDX system that confers resistance to Cd(2+) and Zn(2+) was identified in Streptococcus salivarius 57.I. Unlike with other CadDX systems, the expression of the cad promoter was negatively regulated by CadX, and the repression was inducible by Cd(2+) and Zn(2+), similar to what was found for CadCA systems. The lower G+C content of the S. salivarius cadDX genes suggests acquisition by horizontal gene transfer.


Subject(s)
Bacterial Proteins/genetics , Cadmium/metabolism , Drug Resistance, Bacterial/genetics , Gene Expression Regulation, Bacterial , Operon/genetics , Streptococcus/genetics , Zinc/metabolism , Base Composition , Base Sequence , DNA Primers/genetics , Gene Library , Molecular Sequence Data , Plasmids/genetics , Sequence Analysis, DNA
4.
World J Gastroenterol ; 3(3): 176, 1997 Sep 15.
Article in English | MEDLINE | ID: mdl-27239142

ABSTRACT

AIM: To evaluate the clinical significance of endocrine-like tumor cells in human colorectal carcinomas. METHODS: The immunohistochemistry method (ABC) using a rabbit polyclonal antibody against human chromogranin A (CGA) was employed to determine changes in endocrine-like tumor cells from the surgically resected colorectal carcinoma tissues of patients (35 males and 27 females, aged from 19 to 78 years, with a mean age of 50.3 years). Of the 62 specimens, 44 were from rectal carcinomas, 18 from colonic carcinomas, 14 from lymph nodes and 48 from non-involvement. Dukes classification revealed 19 of the cases were in stage A, 29 cases were in stage B and 14 cases were in stage C. All of the specimens were fixed with 10% formalin, embedded with paraffin and cut into 5 µm sections. Additionally, the correlations among CGA-positive tumor cells, as well as the clinicopathologic data, age and sex of the patients, were also investigated. RESULTS: CGA-positive tumor cells were found in 35.5% of the patients with colorectal cancers, representing 20.0% (5 of 25) and 45.9% (17 of 37) of the aged and non-aged, respectively. These differences were significant (χ(2) test, P < 0.05). Nevertheless, no significant correlations were found between the CGA-positive tumor cells and the sex, Dukes stages, tumor location, degree of histological differentiation or presence of lymph node metastasis. CONCLUSION: The low incidence of endocrine-like tumor cells found in the aged patients may be a new pathological feature for colorectal carcinomas, which could explain why the aged patients usually had a better prognosis. The exact significance of these findings requires further characterization.

SELECTION OF CITATIONS
SEARCH DETAIL
...